PATENT CLAIM ANALYSIS

Application Number: 16085234
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "130100"]

Abstract:
The present invention provides for a new therapeutic tools capable of treating infectious diseases, in particular, a new pharmaceutical composition comprising an IgM-enriched immunoglobulin preparation for use in the adjunctive treatment of severe Community Acquired Pneumonia (sCAP).

Claim (Index 14):
The immunoglobulin preparation for use according to  claim 1 , being in the form of a solution for intravenous administration comprising between 40 and 100 gram immunoglobulin per liter solution, preferably between 40 and 60 gram immunoglobulin per liter solution.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13817414', '14529400', '13655686', '15348121', '14778114']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6577168382636807
- 35 USC 102 Novelty (BERT): 0.5056105062894014
- Combined Prediction Score: 0.6425062050662528
- Mean Citation Score: 230.49716
- Max Citation Score: 256.71954
- Similarity Product: 193.9088184535861

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test